Sign in / Join Now
ETFs & Funds
2nd is $
Myriad Genetics. Cancer and other diagnostic medicines. Great margins, balance sheet, 20%+ LT growth rate.
Add a reply...
Latest StockTalks »
people get MYGN breaking news and analysis by email alert.
Get email alerts on MYGN »
Myriad Genetics, Inc.
Get latest price
From other sites
The Myriad MyPath® Melanoma Test Effectively Diagnosed Patients In The Largest Outcomes-Based Study For A Melanoma Diagnostic
at TheStreet (Thu, 7:05AM)
Exclusive: Myriad Genetics Discusses The Growing Market In Genetic Testing
at Benzinga (Wed, 10:20AM)
Myriad's BRACAnalysis CDx® Test Identifies Patients With Ovarian Cancer Who Would Benefit From Second-Line Maintenance Treatment With Olaparib
at TheStreet (Wed, 7:15AM)
Myriad RBM Announces An Agreement With Sanofi To Measure Predictive Cardiovascular Biomarkers In Patients With Diabetes
at TheStreet (Tue, 7:05AM)
Myriad Genetics (MYGN) Q1 Earnings: A Beat in the Cards?
at Zacks.com (Mon, 10:01AM)